Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease

Files
41591_2022_Article_2037.pdf (549.54 KB)
Date
2022
Authors
Milà-Alomà, Marta
Ashton, Nicholas J.
Shekari, Mahnaz
Salvadó, Gemma
Ortiz-Romero, Paula
Montoliu-Gaya, Laia
Benedet, Andrea L.
Karikari, Thomas K.
Lantero-Rodriguez, Juan
Vanmechelen, Eugeen
Day, Theresa A.
González-Escalante, Armand
Sánchez-Benavides, Gonzalo
Minguillon, Carolina
Fauria, Karine
Molinuevo, José Luis
Dage, Jeffrey L.
Zetterberg, Henrik
Gispert, Juan Domingo
Suárez-Calvet, Marc
Blennow, Kaj
Language
American English
Embargo Lift Date
Department
Neurology, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Abstract

This corrects the article "Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease" in Nat Med, volume 28 on page 1797.

Description
Keywords
Predictive markers, Alzheimer's disease, Amyloid beta-peptides, Positron-emission tomography
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Milà-Alomà M, Ashton NJ, Shekari M, et al. Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease. Nat Med. 2022;28(9):1965. doi:10.1038/s41591-022-02037-1
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Nature Medicine
Rights
Attribution 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/35244
DOI
https://doi.org/10.1038/s41591-022-02037-1
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Neurology Works